The Indian Pharmaceutical Market (IPM) exhibited substantial growth in Q1 2023, with market size reaching ₹50,361 Cr., marking a 15% increase. Key drivers include a 26% rise in new product launches and balanced expansion in both acute and chronic therapeutic segments. Notable growth was seen in anti-infectives (28%) and chronic respiratory therapies (29%). Indian companies led the growth at 16%, surpassing multinational companies’ 10% growth, with top local firms like Sun and Cipla performing well. Regionally, the South and North zones emerged as significant contributors, and growth was observed in both Metro and Tier-2 cities, indicating potential job opportunities in roles such as Pharmacovigilance Associate across diverse locations.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.pw.live/online-degree/exams/pharmacovigilance-associate-jobs-metro-vs-tier-2-cities
